Need a mesothelioma lawyer? We will fight for you!
› $150,000,000 verdict in personal injury case
The more than 2 million baby-boomer women who are approaching menopause may find themselves in a precarious position when it comes to handling hot flashes and mood swings. Should they risk the threat of breast cancer from use of hormone replacement therapy, or simply suffer through the agonizing symptoms? According to Forbes, new and detailed research offers women the opportunity to make a more educated decision.
A federal study revealed that the pharmaceutical company Wyeth paid ghostwriters to write articles for medical journals that were favorable to the drug company’s hormone replacement therapy (HRT) Prempro, even after the drug was found to raise a woman’s risk for breast cancer, according to the New York Times.
Hormone replacement therapy (HRT) and its link to breast cancer and other serious conditions continue to make headlines. This week, U.S. News & World Report announced that women who take HRT and then get breast cancer are at lower risk of dying from their disease, according to a new study by the University of California-Irvine.
A study in the Journal of the American Medical Association (JAMA) reveals that women who took hormone replacement therapy (HRT) face an increased risk of cancer several years after stopping the treatment, according to an NPR report.
Overweight women suffer more hot flashes during menopause than women who maintain a normal weight, according to the Hartford Courant. The news story references a study published by the American Journal of Epidemiology that debunks an earlier belief that menopausal women who were heavier experienced fewer hot flashes than thin women.
How can you tell if the physical symptoms you are experiencing are from menopause or from a much more serious problem like a heart attack? Dr. Jeff Hersh, a columnist with the Taunton Daily Gazette, recently addressed this question, noting that there are several misconceptions about heart disease in women that first must be understood.
Women who take breast cancer drugs Arimidex or generic tamoxifen and suffer with menopausal symptoms such as hot flashes, night sweats or painful joints may be less likely to have a reoccurrence of their cancer tumors, according to Reuters.
Years before the onset of menopause, women can begin to feel many of the symptoms as part of perimenopause, according to a story by AsiaOne.
Perimenopause is the body’s natural transition toward menopause. This is period leading up to menopause – anywhere from two to eight years – as well as the first year after a woman’s last menstrual cycle.
October is breast cancer awareness month, which makes it a perfect time for women currently taking or considering taking hormone replacement therapy (HRT), to assess their breast health.
![[ Beasley Allen Law Firm Logo ]](http://www.hrt-legal.com/wp-content/themes/system-unity/images/logo.png){kind=logo}
